We are live on ! Find out more
Jim Simons

Jim Simons Renaissance Technologies

AUM $63.9B
1-Year Est. Return 45.56%
 

Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.

This Fund
S&P 500
This Quarter Est. Return
+8.19%
1 Year Est. Return
+45.56%
3 Year Est. Return
+129.95%
5 Year Est. Return
+153.6%
10 Year Est. Return
+738.31%
AUM
$73.1B
AUM Growth
+$2.4B
Cap. Flow
-$1.43B
Cap. Flow %
-1.96%
Top 10 Hldgs %
11.25%
Holding
4,601
New
626
Increased
1,390
Reduced
2,018
Closed
524

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$839M
2
AMZN icon
Amazon
AMZN
+$810M
3
TSLA icon
Tesla
TSLA
+$644M
4
TSM icon
TSMC
TSM
+$546M
5
JNJ icon
Johnson & Johnson
JNJ
+$389M

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$891M
2
HD icon
Home Depot
HD
+$441M
3
JPM icon
JPMorgan Chase
JPM
+$335M
4
NVO
Novo Nordisk
NVO
+$317M
5
ASML icon
ASML
ASML
+$315M

Sector Composition

Rank Sector Weight
1 Healthcare 20.81%
2 Technology 15.51%
3 Consumer Discretionary 11.84%
4 Consumer Staples 10.09%
5 Financials 9.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FMTX
4576
DELISTED
Forma Therapeutics Holdings, Inc. Common Stock
FMTX
-700,100
Closed -$14M
RMO
4577
DELISTED
Romeo Power, Inc.
RMO
-1,487,836
Closed -$595K
TGA
4578
DELISTED
Transglobe Energy Corp
TGA
-3,007,301
Closed -$8.06M
CVET
4579
DELISTED
Covetrus, Inc. Common Stock
CVET
-190,702
Closed -$3.98M
EXTN
4580
DELISTED
Exterran Corporation
EXTN
-49,800
Closed -$207K
TMX
4581
DELISTED
Terminix Global Holdings, Inc.
TMX
-102,297
Closed -$3.92M
IEA
4582
DELISTED
Infrastructure and Energy Alternatives, Inc. Common Stock
IEA
-558,100
Closed -$7.56M
RNDB
4583
DELISTED
Randolph Bancorp, Inc. Common Stock
RNDB
-9,200
Closed -$248K
GBT
4584
DELISTED
Global Blood Therapeutics, Inc.
GBT
-283,700
Closed -$19.3M
DRE
4585
DELISTED
Duke Realty Corp.
DRE
-241,800
Closed -$11.7M
BXRX
4586
DELISTED
Baudax Bio, Inc. Common Stock
BXRX
-6,038
Closed -$59K
FBC
4587
DELISTED
Flagstar Bancorp, Inc. New
FBC
-67,309
Closed -$2.25M
CTIC
4588
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
-26,520
Closed -$154K
BSCM
4589
DELISTED
Invesco BulletShares 2022 Corporate Bond ETF
BSCM
-330,300
Closed -$7M
AHI
4590
DELISTED
Advanced Health Intelligence Ltd
AHI
-10,773
Closed -$23K
EBIX
4591
DELISTED
Ebix Inc
EBIX
-12,080
Closed -$229K
YELL
4592
DELISTED
Yellow Corporation Common Stock
YELL
-391,800
Closed -$1.99M
AAWW
4593
DELISTED
Atlas Air Worldwide Holdings, Inc.
AAWW
-213,400
Closed -$20.4M
EVK
4594
DELISTED
Ever-Glory International Group, Inc.
EVK
-32,800
Closed -$28K
IBDN
4595
DELISTED
iShares iBonds Dec 2022 Term Corporate ETF
IBDN
-123,500
Closed -$3.09M
NTP
4596
DELISTED
Nam Tai Property Inc.
NTP
-131,600
Closed -$55K
MTL.PR
4597
DELISTED
Mechel PAO American Depositary Shares (each representing one-half of a Preferred Share)
MTL.PR
-898,438
Closed -$108K
MTL
4598
DELISTED
Mechel PAO American Depository Shares, each representing two ordinary shares (ADSs)
MTL
-1,545,087
Closed -$348K
SVA
4599
DELISTED
Sinovac Biotech, Ltd
SVA
-2,375,841
Closed -$1.54M
RNWK
4600
DELISTED
RealNetworks Inc
RNWK
-1,486,164
Closed -$1.03M

Similar funds

Jim Simons's Q4 2022 Portfolio in Review

As of Q4 2022, Jim Simons held 4,601 positions worth $73.1B, up 3.4% from $70.7B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Jim Simons's Q4 2022 filing shows 626 new, 1,390 increased, 2,018 reduced and 524 closed positions. Its largest new stake was Johnson & Johnson: 2,254,125 shares worth $398M. The largest sale was Microsoft, an estimated $891M.

By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 19% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Jim Simons's largest Q4 2022 buy was Johnson & Johnson: 2,254,125 shares worth $398M.
  • Jim Simons added most to Apple in Q4 2022, an estimated $839M increase.
  • Jim Simons's biggest Q4 2022 reduction was Novo Nordisk, cutting an estimated $317M.
  • Jim Simons fully exited Microsoft in Q4 2022, selling an estimated $891M.
  • Jim Simons's ten largest holdings make up 11% of its $73.1B portfolio in Q4 2022.
  • Jim Simons opened 626 new positions and closed 524 in Q4 2022.
  • Jim Simons's portfolio value rose 3.4% quarter-over-quarter to $73.1B.

Based on Renaissance Technologies's 13F filing for Q4 2022, filed 13 Feb 2023.